LDL cholesterol, often called “bad” cholesterol, is significant in heart health. It’s a waxy substance in the blood that can accumulate in artery walls, forming plaque. This plaque buildup, known as ...

Trials of a new cholesterol-lowering pill have shown promising results for people with heterozygous familial hypercholesterolemia (HeFH), a genetic disorder that leads to high levels of LDL ...

Despite common assumptions, maintaining a standard cholesterol reading does not fully shield individuals from heart attacks. Dr. Vassily Eliopoulos, a leading physician in preventative cardiology and ...

High cholesterol is a major risk factor for heart disease and stroke, two leading causes of death in the U.S. Lifestyle changes like a heart-healthy diet, regular exercise, and quitting smoking can ...

A new daily pill could reduce bad cholesterol levels by 60%, according to a new study. Enlicitide, which was developed by Merck, lowered “bad” LDL cholesterol by more than half in a global study ...

A new medication that combines an already approved drug with a new unapproved one has been shown to cut the level of LDL, or “bad” cholestero l, when statins aren’t helping enough. In the Phase 3 ...

A new study explores the cholesterol-lowering effects of a new drug called enlicitide. Nicole Mason/Stocksy A recent study, published in JAMA on November 9, investigates a drug called enlicitide. The ...